Dr. Felix was born and raised in Tarragona, Spain – a port city in northeastern Spain’s Catalonia region. From 2016 to 2021 he performed his doctoral studies at the University of Barcelona under the guidance of Dr. Carlos Ciudad and Dr. Veronica Noe, where Dr. Felix developed therapeutic oligonucleotides for gene silencing applications in cancer, as well as gene correction approaches for rare genetic diseases. After receiving his PhD, Dr. Felix’s interest to work on RNA therapies for rare disorders in a more translational and clinically relevant context prompted him to move to the United States and join the laboratory of Dr. Benjamin Prosser at the University of Pennsylvania as a postdoctoral researcher. He is part of a team that is actively working together to develop and translate novel therapeutic strategies for rare neurodevelopmental disorders, including STXBP1 and SYNGAP1 encephalopathies. Away from the lab, Dr. Felix enjoys hiking, movies, rap music, and video games.
Alex Felix
